Before a patient is registered for PRRT treatment at the PRRT Treatment Center Rotterdam, we would like to receive the following information:
- Referral letter with relevant medical history of the patient.
- CT-scan (not older than 3 months). Note: we would like to receive the original studies on a CD/DVD and the original report. A report by itself is not sufficient.
- Indium octreotide scan (SRS/OctreoScan) (not older than 6 months). Note: we would like to receive the original studies on a CD, a report by itself is not sufficient.
- Pathology Report (primary and/or metastasis).
- blood tests: Sodium, Potassium, Calcium, Phosphate, Urea, Creatinine, Alkaline Phosphatase, Gamma GT, AST, ALT, LD, total bilirubin, albumin, total protein, Hb, MCV, Leukocytes and Thrombocytes/Platelets, tumor markers (when available).
- Creatinine clearance (ml/min) and 5-HIAA in 2 x 24 hour urine.
You can send us this information per post or courier.
Steps after Registration
When the above information has been received in good order and is complete, the referring physician and the patient will receive an email confirmation. If there is information missing, we will request it. Thereafter, all the information will be discussed internally by the physicians of the PRRT Treatment Center and in the NET multidisciplinary tumor board, and it will be decided whether the patient is eligible for PRRT. Hereafter, the referring physician and the patient will be contacted to inform about the outcome. If eligible, the day of the first PRRT will be set.
One day before the first PRRT cycle, the patient will have an interview and bloodwork.
It is possible that a patient is evaluated at the Endocrinological Unit of the Erasmus MC before treatment. Part of the required research can then take place in the Erasmus MC.
Overview PRRT Steps
For a visual overview of the various steps before, during and after treatment, view the following schematic representations: